IDXX Idexx Laboratories Inc
- Stocks
- Healthcare
- NASDAQ: IDXX
Price (delayed)
$703.02
Market cap
$56.14B
P/E Ratio
55.27
Dividend/share
N/A
EPS
$12.72
Enterprise value
$57.02B
Relative Growth:
Rel. Growth:
85
Relative Strength:
Rel. Strength:
84
Relative Valuation:
Rel. Valuation:
18
Relative Profitability:
Rel. Profitability:
97
IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and
Highlights
The company's EPS rose by 21% YoY and by 5% QoQ
The company's net income rose by 19% YoY and by 4.2% QoQ
The quick ratio has decreased by 23% YoY but it has increased by 5% QoQ
The debt has grown by 11% YoY but it has contracted by 10% from the previous quarter
IDXX's price to earnings (P/E) is 32% higher than its last 4 quarters average of 42.8 and 4.5% higher than its 5-year quarterly average of 54.2
Key stats
What are the main financial stats of IDXX
Market
Valuations
Earnings
Shares outstanding
79.85M
Market cap
$56.14B
Enterprise value
$57.02B
Price to earnings (P/E)
55.27
Price to book (P/B)
36.03
Price to sales (P/S)
13.51
PEG
2.57
EV/EBIT
43.5
EV/EBITDA
39.3
EV/Sales
13.68
Revenue
$4.17B
Gross profit
$2.57B
Operating income
$1.31B
Net income
$1.03B
EBIT
$1.31B
EBITDA
$1.45B
Free cash flow
$953.57M
Per share
Balance sheet
Liquidity
EPS
$12.72
EPS diluted
$12.61
Free cash flow per share
$11.91
Book value per share
$19.51
Revenue per share
$52.03
TBVPS
$35.69
Total assets
$3.39B
Total liabilities
$1.83B
Debt
$1.09B
Equity
$1.56B
Working capital
$225.24M
Debt to equity
0.7
Current ratio
1.18
Quick ratio
0.62
Net debt/EBITDA
0.61
Margins
Efficiency
Dividend
EBITDA margin
34.8%
Gross margin
61.7%
Net margin
24.7%
Operating margin
31.3%
Return on assets
31.1%
Return on equity
67.8%
Return on invested capital
52.7%
Return on capital employed
61.4%
Return on sales
31.5%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
IDXX stock price
How has the Idexx Laboratories stock price performed over time
Intraday
-2.39%
1 week
11.85%
1 month
11.99%
1 year
66.03%
YTD
70.04%
QTD
10.04%
Financial performance
How have Idexx Laboratories's revenue and profit performed over time
Revenue
$4.17B
Gross profit
$2.57B
Operating income
$1.31B
Net income
$1.03B
Gross margin
61.7%
Net margin
24.7%
The company's net income rose by 19% YoY and by 4.2% QoQ
IDXX's operating income is up by 17% YoY and by 4.1% from the previous quarter
The net margin has grown by 10% YoY
The gross profit has increased by 10% YoY and by 3.5% QoQ
Price vs fundamentals
How does IDXX's price correlate with its fundamentals
Growth
What is Idexx Laboratories's growth rate over time
Valuation
What is Idexx Laboratories stock price valuation
P/E
55.27
P/B
36.03
P/S
13.51
EV/EBIT
43.5
EV/EBITDA
39.3
EV/Sales
13.68
IDXX's price to earnings (P/E) is 32% higher than its last 4 quarters average of 42.8 and 4.5% higher than its 5-year quarterly average of 54.2
The company's EPS rose by 21% YoY and by 5% QoQ
The price to book (P/B) is 38% more than the last 4 quarters average of 26.8 but 21% less than the 5-year quarterly average of 46.6
The company's equity rose by 7% QoQ but it fell by 3.5% YoY
The P/S is 37% above the last 4 quarters average of 10.1 and 13% above the 5-year quarterly average of 12.2
IDXX's revenue is up by 8% year-on-year and by 3.2% since the previous quarter
Efficiency
How efficient is Idexx Laboratories business performance
Idexx Laboratories's return on equity has increased by 22% YoY and by 5% QoQ
The return on assets rose by 20% year-on-year and by 4% since the previous quarter
Idexx Laboratories's return on invested capital has increased by 16% YoY and by 3.9% QoQ
The company's return on sales rose by 8% YoY
Dividends
What is IDXX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for IDXX.
Financial health
How did Idexx Laboratories financials performed over time
The company's total assets is 86% higher than its total liabilities
The quick ratio has decreased by 23% YoY but it has increased by 5% QoQ
IDXX's current ratio is down by 17% year-on-year but it is up by 6% since the previous quarter
The debt is 30% less than the equity
IDXX's debt to equity is up by 17% YoY but it is down by 16% QoQ
The debt has grown by 11% YoY but it has contracted by 10% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.